Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tutogen purchase plan scuttled

This article was originally published in The Gray Sheet

Executive Summary

Tissue product manufacturer remains public after ending acquisition negotiations with an unspecified private equity firm. On Nov. 4, Tutogen Medical announced that the equity firm offered to buy the West Paterson, N.J. company for $94 mil. (1"The Gray Sheet" Nov. 10, 2003, In Brief). CEO Manfred Kruger cites "questions about the possibilities of this potential transaction closing by early 2004" as reason for the deal's demise...
Advertisement

Related Content

Tutogen for sale
Advertisement
UsernamePublicRestriction

Register

MT019570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel